Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,070.00
-200.00 (-2.42%)
Sep 11, 2026, 3:30 PM KST

KRX:007570 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12,86523,6544,2953,4147,1749,288
Short-Term Investments
4,8735,9738,49510,2765,41934,111
Trading Asset Securities
-----231.78
Cash & Short-Term Investments
17,73829,62712,79013,69012,59343,631
Cash Growth
6.99%131.64%-6.57%8.72%-71.14%4.85%
Accounts Receivable
37,78744,97244,77747,65648,76252,803
Other Receivables
10,0823,9403,9364,6804,7163,297
Receivables
47,86948,91248,71352,33653,47956,101
Inventory
67,51464,24359,87353,10848,38732,423
Prepaid Expenses
561.26651.12158.02186.42303.23515.3
Other Current Assets
2,1374,3293,6524,3393,6563,671
Total Current Assets
135,818147,762125,187123,659118,418136,340
Property, Plant & Equipment
222,424220,675216,421181,973178,244175,779
Long-Term Investments
44,89540,67843,51038,57252,84745,029
Other Intangible Assets
1,7401,7121,8881,8261,9352,078
Long-Term Deferred Charges
24,32824,03923,45325,53029,48134,392
Other Long-Term Assets
22,51622,46420,56821,04621,99125,643
Total Assets
451,721457,331431,027392,607402,916419,261

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
21,52920,70422,32226,30729,81323,717
Accrued Expenses
428.46480.55513.8398.44310.58314.19
Short-Term Debt
74,80096,21692,50565,78971,00092,500
Current Portion of Long-Term Debt
3,3333,333--2,000-
Current Portion of Leases
348.06189.5266.59522.11370.52159.24
Current Income Taxes Payable
8.63236.41,2931,126958.543,542
Other Current Liabilities
54,38650,01240,64945,12140,87547,687
Total Current Liabilities
154,833171,172157,549139,263145,328167,920
Long-Term Debt
25,00026,66714,7006,000-5,000
Long-Term Leases
188.6388.51209.38339.24732.69843.73
Pension & Post-Retirement Benefits
6,7157,0188,5807,3227,9098,136
Long-Term Deferred Tax Liabilities
5,5878,2278,5659,23310,66210,464
Other Long-Term Liabilities
2,4602,4501,8915050021.5
Total Liabilities
194,784215,922191,494162,207165,132192,385

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
47,71447,71447,71447,71447,71447,714
Additional Paid-In Capital
78,37078,37078,37078,44178,41678,590
Retained Earnings
132,500122,790118,75953,55958,75943,170
Treasury Stock
-12,269-12,269-11,269-11,921-10,075-7,437
Comprehensive Income & Other
5,991-114.371,26457,95758,49660,587
Total Common Equity
252,306236,490234,838225,751233,311222,624
Minority Interest
3,5183,8053,5823,5363,3613,139
Shareholders' Equity
256,937241,409239,533230,400237,785226,876
Total Liabilities & Equity
451,721457,331431,027392,607402,916419,261

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
103,670126,794107,68172,65074,10398,503
Net Cash (Debt)
-85,932-97,168-94,891-58,960-61,511-54,872
Net Cash Growth
------
Net Cash Per Share
-4941.86-5414.14-5148.09-3272.13-3393.60-3014.10
Filing Date Shares Outstanding
17.9217.9218.0117.9718.0918.21
Total Common Shares Outstanding
17.9217.9218.0117.9718.0918.21
Working Capital
-19,016-23,410-32,362-15,604-26,910-31,580
Book Value Per Share
14075.6913193.3513036.8712561.4212899.4512228.63
Tangible Book Value
250,566234,778232,951223,925231,375220,547
Tangible Book Value Per Share
13978.5913097.8512932.0712459.7912792.4612114.49
Land
118,556118,556120,507120,298120,308116,955
Buildings
38,68439,55841,12642,78744,47445,995
Machinery
3,3872,9944,0556,0609,3679,480
Construction In Progress
60,29858,41549,58311,4352,3841,953